Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fischer

Showing results (291-300 of 323) with videos related to

Pageof 33
Sort By:
Cancer Discovery|August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified CancersGiulia Montuori, Fengyu Tu, Di Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Pageof 33

Showing results (291-300 of 323) with videos related to

Sort By:
Pageof 33
Cancer Discovery|August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified CancersGiulia Montuori, Fengyu Tu, Di Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Pageof 33